Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relationships between time in target range and A1C (25; 26) and number of severe and non-severe hypoglycemic events (27-31) have also been observed.”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [31]
In the citing paper
“Nevertheless, our analysis in people without diabetes are in line with the International Hypoglycaemia Study Group (IHSG) classification for hypoglycaemia, particularly regarding level 1 hypoglycaemia [78].”
From Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review (2022) · cites this paper as [78]
In the citing paper
“The severity of hypoglycemia is not strictly defined by glucose levels, but is characterized by the severity of the associated symptoms of hypoglycemia and risks, as defined by the International Hypoglycemia Study Group [14] (Tables 2 and 3).”
From Hypoglycemia in Adults (2023) · cites this paper as [14]
Citations
Cites
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009 · cited 1×
“NICE-SUGAR trial (23) and, possibly, in”
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403
Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Research works printed but not linked: 1
- Cryer, 2001, The prevention and correction of hypoglycemia, 1057
Cited by
Items 401–500 of 615
Diabetes in the Workplace: the Hazards of Hypoglycemia
Gerbo, R., Jin, C. F., & Clark, K. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1234-2 · Cited by 5
Bolli, G. B., Landgraf, W., Bosnyák, Z., Melas‐Melt, L., & Home, P. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14065 · Cited by 5
Jermendy, G., Kecskés, Á., & Nagy, A. C. (2021) · Medicina · doi:10.3390/medicina57020167 · Cited by 6
Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., González‐González, J. G., & McCoy, R. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001906 · Cited by 5
N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus
Đelmiš, J., Ivanišević, M., & Horvatiček, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122082 · Cited by 5
Oba, T., Nagao, M., Kobayashi, S., Yamaguchi, Y., Nagamine, T., Tanimura‐Inagaki, K., Fukuda, I., & Sugihara, H. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221099349 · Cited by 7
Yen, F., Hou, M., Pan, C., Liu, J., Hsu, C., & Hwu, C. (2022) · Diabetes Care · doi:10.2337/dc22-1349 · Cited by 5
Hortensius, J., Kleefstra, N., Landman, G. W. D., Houweling, B. T., Groenier, K. H., van der Bijl, J. J., & Bilo, H. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3138-7 · Cited by 4
RSSDI guidelines for management of type 2 diabetes mellitus in older adults
Jagadeesha, A., Viswanathan, V., Agarwal, S., Maheshwari, A., Virmani, A. K., Nagendra, L., Amarnath, A., Chawla, M. S., Jethwani, P., Parikh, R. M., et al. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01613-8 · Cited by 4
Prevalence of post-bariatric hypoglycemia in the United States
Craig, C. M., Ramanujan, S., & McLaughlin, T. (2026) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2026.03.013 · Cited by 6
Hevesi, J. I. (2024) · Belügyi Szemle · doi:10.38146/bsz.2024.1.5 · Cited by 4
Dey, A. K., Gokalani, R. A., Kale, M. C., Sankar, P., Saboo, B., Maheshwari, A., Jaggi, S., Jagadeesha, A., Panchal, D., Chawla, M. S., et al. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_121_23 · Cited by 5
Zammitt, N. N., Forbes, S., Inkster, B., Strachan, M. W. J., Wright, R. J., Dover, A. R., Stimson, R. H., & Gibb, F. W. (2025) · Diabetic Medicine · doi:10.1111/dme.70074 · Cited by 5
Kahkoska, A. R., Crandell, J., Driscoll, K. A., Kichler, J., Seid, M., Mayer‐Davis, E. J., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12805 · Cited by 4
Uduku, C. N., Pendolino, V., Jugnee, N., Oliver, N. S., Fothergill, R. T., & Reddy, M. (2023) · Diabetic Medicine · doi:10.1111/dme.15100 · Cited by 5
Nielsen, B. U., Mathiesen, I. H. M., Møller, R., Krogh‐Madsen, R., Katzenstein, T. L., Pressler, T., Shaw, J., Ritz, C., Rickels, M. R., Stefanovski, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1249876 · Cited by 4
Metabolic and endocrine evaluation of islet transplant function
Rickels, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00045-9 · Cited by 6
Akın, S., Bölük, C., Ozgur, Y., Aladağ, N., Geçmez, G., Keskin, O., Boru, U. T., & Tasdemir, M. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.311 · Cited by 4
A general view of epidemiology of hypoglycemia in type 1 and type 2 diabetes mellitus
Brož, J., & Urbanová, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.050 · Cited by 5
Farrell, C. M., McNeilly, A. D., West, D. J., & McCrimmon, R. J. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.166 · Cited by 4
Hundert Jahre – Insulin bleibt aktuell und notwendig
Landgraf, R., & Aberle, J. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1386-0011 · Cited by 8
Garden, G. L., Frier, B. M., Hine, J. L., Hutchison, E. J., Mitchell, S. J., Shaw, K. M., Heller, S. R., Koehler, G., Hofmann, V., Gaffney, T. P., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14471 · Cited by 5
Davies, M. J., Rosenstock, J., Ali, A., Russell-Jones, D. L., Souhami, E., PALMER, K. D., Ji, C. F., Niemoeller, E., & SKOLNIK, N. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14543 · Cited by 4
Urbanová, J., Frier, B. M., Taniwall, A., Brožová, K., Malinovská, J., Chandel, A., & Brož, J. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.03.011 · Cited by 5
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00769-1 · Cited by 5
“International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0mmol/L (54mg/dL) should be reported in clinical trials: ajointpositionstatementoftheAmericanDiabetes Association and the European Association for the StudyofDiabetes.”
Bond, Z., Malik, S., Bashir, A., Stocker, R., Buckingham, J., Speight, J., & Shaw, J. (2023) · Transplant International · doi:10.3389/ti.2023.11659 · Cited by 5
Landgraf, W., Owens, D. R., Frier, B. M., & Bolli, G. B. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15336 · Cited by 4
Harris, C. J., Forst, T. M., Heise, T., Plum‐Mörschel, L., Watkins, E., Zhang, Q., Fan, L., Garhyan, P., & Pørksen, N. K. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0414 · Cited by 4
Dasiglucagon in severe hypoglycemia: a profile of its use
Syed, Y. Y. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00894-x · Cited by 4
Lin, J., Zhang, J., Liang, B., Lin, J., Wang, N., Lin, J., & Huang, H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01242-3 · Cited by 3
Zou, Y., Jiang, F., Sun, C., Zhao, C., Qian, H., Jia, J., Yu, C., Chen, H., Wang, M., & Chen, Q. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16080 · Cited by 3
DEVORE, M. H., Hepworth, E., Agni, A., Ye, W., Amiel, S. A., Fisher, S. J., & Lin, Y. K. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0126 · Cited by 3
MCCARTHY, A. M., THOMAS, J. J. C., Avila, E., Koutroukas, V., Pieri, B. A., Zaremba, N., Amiel, S. A., Pouwer, F., Choudhary, P., & Divilly, P. (2026) · Diabetic Medicine · doi:10.1111/dme.70194 · Cited by 3
Unmasking Hirata: a mysterious case of Hypoglycemia triggered by immunologic storm
AbuBaha, M., Salameh, H., Abubaha, B., Dahabreh, Y., Marouf, O., Atary, M., Qubaja, H., Mansor, A., & Taha, H. M. (2025) · Oxford Medical Case Reports · doi:10.1093/omcr/omaf289 · Cited by 3
Dholariya, S. J., Parchwani, D. N., Dutta, S., & Singh, R. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2138343 · Cited by 3
Abusamaan, M. S., Klonoff, D. C., & Mathioudakis, N. N. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883332 · Cited by 3
“Despite health-system wide policies recommending TTR within 15 minutes of hypoglycemia treatment, the median (IQR) TTR was 49 (25-119) minutes.”
BackgroundInfluentialLoumpardia, P., & Huda, M. S. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88674 · Cited by 3
Treatment of type 1 diabetes complicated by problematic hypoglycemia
Jacob, P., CHANDRAN, S. R., & Choudhary, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00032-0 · Cited by 3
Hypoglycemic risk exposures in relation to low serum glucose values in ambulatory patients
Abusamaan, M. S., Marzinke, M. A., Ashok, A., Carroll, K. C., Lane, K. L., Jeun, R., Moseley, K. F., Carson, K. A., & Mathioudakis, N. N. (2020) · Medicine · doi:10.1097/md.0000000000018679 · Cited by 3
How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?
Home, P. D. (2020) · Diabetes Care · doi:10.2337/dci19-0056 · Cited by 3
Influence of Ethnicity on Outcomes of Diabetes Inpatient Hypoglycemia: an Australian Perspective
Malabu, U. H., Adegboye, O. A., Hayes, O. G., Ryan, A., Vangaveti, V., Jhamb, S., Robertson, K., & Sangla, K. S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa009 · Cited by 4
Habteab, A., Castañeda, J., de Valk, H. W., Choudhary, P., Bosi, E., Lablanche, S., de Portu, S., Silva, J. D., Vorrink, L., Shin, J., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0495 · Cited by 3
Analysis of recurrent hypoglycemic events
Ma, C., Qu, Y., & Fu, H. (2020) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2020.1765370 · Cited by 3
Differential diagnosis of hypoglycemia
Schovánek, J., Cibičková, Ľ., Čtvrtlík, F., Fryšák, Z., & Karásek, D. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.022 · Cited by 4
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_22 · Cited by 3
A view at postbariatric hypoglycemia by endocrinologist
Kim, E. I., Ershova, E. V., Mazurina, N. V., & Komshilova, K. A. (2022) · Obesity and metabolism · doi:10.14341/omet12785 · Cited by 3
Rydosz, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99887-1.00001-7 · Cited by 4
Bonhoure, A., Potter, K. J., Reynaud, Q., Boudreau, V., Senior, P. A., Tremblay, F., Lavoie, A., Durieu, I., & RABASA-LHORET, R. P. R. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.11.004 · Cited by 3
McCrimmon, R. J., Home, P., CHENG, A. Y. Y., Giorgino, F., Fonseca, V. A., Souhami, E., Alvarez, A., Picard, P., & Rosenstock, J. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14825 · Cited by 3
Kuchay, M. S., Mathew, A., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Jain, R., Gagneja, S., Kohli, C., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.15002 · Cited by 3
Stuckey, H. L., Desai, U. S., Mitchell, B. D., & Pearson, T. L. (2023) · Diabetic Medicine · doi:10.1111/dme.15084 · Cited by 3
Shah, V. N., Al‐Karadsheh, A., Barnes, C., Mandry, J., Nakhle, S., Wernicke‐Panten, K., Kramer, D., Schmider, W., Pierre, S., Teichert, L., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241232709 · Cited by 4
Chen, L., Wen, B., Liu, H., Wu, H., Duan, B., Shu, H., Zhang, Q., Wu, X., Li, M., Han, Y., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15814 · Cited by 3
“The exploratory endpoint was change from baseline to week 24 in the Diabetes Treatment Satisfaction Questionnaire, status version (DTSQs) score.”
Acquired Metabolic Diseases: Imaging Patterns
Hsu, C. C.-T., & Krings, T. (2019) · Springer eBooks · doi:10.1007/978-3-319-68536-6_69 · Cited by 3
Hypoglycemia awareness and burden among hospitalized patients at high risk for hypoglycemia
Long, C., & Dungan, K. M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107521 · Cited by 3
Mariën, I., Block, C. E. M. D., Verrijken, A., Dessel, K. V., PEIFFER, F. W., Verhaegen, A. A., Hubens, G., Gaal, L. V., & Dirinck, E. L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14130 · Cited by 4
Ruan, Y., Moysova, Z., Tan, G. D., Lumb, A. N., Davies, J., & Rea, R. D. (2020) · Age and Ageing · doi:10.1093/ageing/afaa212 · Cited by 3
Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
Holder, M., Kapellen, T. M., Ziegler, R., Bürger-Büsing, J., Danne, T., Dost, A., Holl, R. W., Holterhus, P., Karges, B., Kordonouri, O., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3388 · Cited by 6
Scarpellini, E., Arts, J., Vanuytsel, T., & Tack, J. F. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00474-5 · Cited by 3
Essuman, V. A., Abaidoo, B., Essuman, A., Akpalu, J., Sackey, A. H., Barnes, N. A., & Amoaku, W. M. K. (2023) · Journal of Advanced Pediatrics and Child Health · doi:10.29328/journal.japch.1001055 · Cited by 2
Hypoglycaemia and monitoring practices following insulin-dextrose therapy for hyperkalaemia
Ford, S., Williams, J. M., Coombes, I., & Caze, A. L. (2025) · JEM Reports · doi:10.1016/j.jemrpt.2025.100142 · Cited by 2
Pellizzari, E., Prendin, F., Cappon, G., Idi, E., Favero, S. D., Herzig, D., Bally, L., & Facchinetti, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-92275-3 · Cited by 2
Fink, J. M., Lühn, M., Meyer-Steenbuck, M., Seifert, G. J., Herrmann, S., Fichtner‐Feigl, S., Seufert, J., Marjanović, G., & Laubner, K. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08245-1 · Cited by 2
“For example, the MMTT cut-off used for PBH in the current trial was 3.3 mmol/l. Possibly, a stricter cut-off of 3 mmol/l or 2.8 mmol/l would have led to a more rigorous patient selection [2, 20].”
InfluentialLandgraf, W., Owens, D. R., Frier, B. M., & Bolli, G. B. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70231 · Cited by 2
Impact of Inhaled Insulin Therapy on Hypoglycemia
Levy, C. J., & Seaquist, E. R. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251381294 · Cited by 3
Fuzzy Modeling of Survival Associated to Insulin Therapy in the ICU
Arévalo, A. R., Firme, B., Vieira, S. M., Celi, L. A., Finkelstein, S. N., & Sousa, J. M. C. (2019) · IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) · doi:10.1109/fuzz-ieee.2019.8858792 · Cited by 2
“One category for hyperglycemic events and three for each severity level of hypoglycemic events, according to [3], [13].”
BackgroundOptimal dosing of gliclazide—A model‐based approach
Mim, S. R., Hussein, H., Vidadi, S., Leisegang, R. F., Karamchand, S., Rambiritch, V., Cotton, M. F., Naidoo, P., & Kjellsson, M. C. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13868 · Cited by 2
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01048-x · Cited by 2
Ooi, S.-W., Yeh, S., Chang, Y., Li, C., & Chen, H.-F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288360 · Cited by 3
Recomendaciones para la práctica clínica: hipoglucemia en personas con diabetes mellitus
Martín, C. G., Loredo, S. D., Forlino, M., Rodríguez, A., Ré, M., Santos, N. C. G., Dimov, L., Apoloni, S. B., Remón, J., Ávila, P. J., et al. (2022) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i2sup.539 · Cited by 4
Urgencias diabetológicas: cetoacidosis, síndrome hiperglucémico hiperosmolar e hipoglucemia
Remartínez, S. G., Valdepérez, M. T., Herranz, J. F., & Bou, B. M. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.11.003 · Cited by 3
An Unusual Case of Hypoglycemia in a Non-diabetic Individual due to Hirata Disease
Tripathy, K. P., Pathi, D., Behera, P. K., Das, S., & Mahesh, S. T. V. (2024) · Cureus · doi:10.7759/cureus.56297 · Cited by 2
Landgraf, W., Owens, D. R., Frier, B. M., & Bolli, G. B. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01608-4 · Cited by 2
“Hypoglycemia was determined according to an internationally agreed definition using a confirmed plasma glucose (PG) value of ≤ 70 mg/dL (≤ 3.9 mmol/L) for level 1 or 54 mg/ dL ( 3.0 mmol/L) for level 2 hypoglycemia [15].”
MethodInfluentialReducing Inpatient Hypoglycemia: A Diversified Approach to a Complex Problem
Lane, A., McKnight, M., Samson, K. K., Nohner, M., & Drincic, A. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.05.744 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Pathophysiology and Management of Type 1 Diabetes
Georga, E. I., Fotiadis, D. I., & Tigas, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804831-3.00002-9 · Cited by 4
McDougal, D. H., Darpolor, M. M., DuVall, M. A., Sutton, E. F., Morrison, C. D., Gadde, K. M., Redman, L. M., & Carmichael, O. T. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1180-5 · Cited by 2
Ng, D., Noor, N. M., & Yong, S. L. (2019) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.034.01.06 · Cited by 2
Design and development of the Hypoglycaemia Symptom Rating Questionnaire (HypoSRQ)
Taylor, M. D., Han, T. S., Ward, H., & Bradley, C. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.010 · Cited by 2
Hypoglycemia: Diagnosis, Management, and Prevention
Faradji, R. N., Uribe-Wiechers, A. C., & Viadero, M. E. S. D. L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_42 · Cited by 2
Dubucs, X., Julla, J., Vidal-Trécan, T., Riveline, J., & Gautier, J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108034 · Cited by 2
Moser, O., Ziko, H., Elsayed, H., Hochfellner, D. A., Pöttler, T., Mueller, A., Eckstein, M. L., Sourij, H., & Mader, J. K. (2020) · Diabetic Medicine · doi:10.1111/dme.14362 · Cited by 4
Chen, H., Xue, Y., He, Y., Chen, H., Li, Y., Chen, Y., & Zhang, Y. (2020) · Heart & Lung · doi:10.1016/j.hrtlng.2020.08.027 · Cited by 2
Hospital care: improving outcomes in type 1 diabetes
BOEDER, S. C., & Kulasa, K. M. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000601 · Cited by 3
“In 2017, the International Hypoglycaemia Study Group (IHSG) proposed new definitions for reporting hypoglycemia in clinical trials [30].”
BackgroundFear of hypoglycemia - the barrier to control of type 1 diabetes mellitus
Chernaya, M. E., & Volkova, A. R. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-1-33-38 · Cited by 2
Aravind, S. R., Singh, K. P., Mogylnytska, L., Zalevskaya, A. G., Matyjaszek‐Matuszek, B., Wernicke‐Panten, K., Nguyên‐Pascal, M., Pierre, S., Rotthaeuser, B., Kramer, D., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01279-z · Cited by 2
Yao, J., Guo, X., Li, S., Han, P., Lv, X., Zhang, X., Mo, Z., Yang, W., Zhang, L., Wang, Z., et al. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2100652 · Cited by 3
Beck, R. W., Raghinaru, D., Calhoun, P. M., & Bergenstal, R. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0462 · Cited by 2
Digital Twin Intervention for Type 2 Diabetes: One-Year Outcomes of a Randomized TrialPreprint
Joshi, S., Shamanna, P., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Shah, L., KAUFMAN, F. R., Mittal, A., Bhagra, S., Liu, S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4499693 · Cited by 3
Chow, E., & Heller, S. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_35 · Cited by 1
Hypoglycemia: varieties of etiopathogenesis and clinic. Observations from practice
Ляшук, П. М., Lіаshuk, R. P., Marchuk, Y. F., Stankova, N. I., & Kudina, M. B. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.4.2022.1178 · Cited by 1
Hypoglycemia: Diagnosis, Management, and Prevention
Faradji, R. N., Uribe-Wiechers, A. C., & de la Maza, E. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_45 · Cited by 2
Russell-Jones, D. L., Bailey, T. S., Lane, W. S., Mathieu, C., & Pedersen‐Bjergaard, U. (2024) · Diabetic Medicine · doi:10.1111/dme.15339 · Cited by 1
“42 However, individuals with type 1 diabetes could potentially use CGM to adjust their treatment pro-actively to reduce time spent in hypoglycaemia through early detection and management of falling blood glucose levels.”
BackgroundNaming hypoglycemia: a narrative tool for young people with type 1 diabetes and their families
do Rosário, F. S., Soares, M., Mesquita, F., & Raposo, J. F. (2024) · Diabetology International · doi:10.1007/s13340-024-00731-8 · Cited by 1
“As previously reported [15, 16], our results illustrate that managing hypoglycemia varies over adolescence, as high-lighted by a young participant when answering Question 3: “but now, I don’t know how, my symptoms have started to change” (G1).”
Hjejle, S., Agesen, R. M., Thorsteinsson, B., Pedersen‐Bjergaard, U., & Brøsen, J. M. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40153 · Cited by 1
Nakshine, V. S., & Keoliya, A. N. (2025) · Multidisciplinary Reviews · doi:10.31893/multirev.2026035 · Cited by 1
Cossu, L., Facchinetti, A., & Bally, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70059 · Cited by 1
Sanke, T., Matsuoka, Y., Kadoya, Y., Yamada, S., Tamagawa, E., & Fujita, A. (2025) · Diabetology · doi:10.3390/diabetology6110138 · Cited by 1
Lin, Y. K., Tang, H., Ye, W., Ratzki‐Leewing, A. A., Lee, J. M., de Zoysa, N., Amiel, S. A., & Herman, W. H. (2025) · Diabetes Care · doi:10.2337/dc25-1778 · Cited by 1
Taguchi, T., Kimura, K., Tsuji, S., Ito, S., Takamura, S., Shimotatara, H., Shimizu, N., Kubo, H., Hoshiyama, A., Hayashi, A., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf193 · Cited by 1
“Hypoglycemia was defined as SGL < 70 mg/dL (3.9 mmol/L), and severe hypoglycemia as SGL < 54 mg/dL [16]; hypoglycemia was additionally classified using the Ademolus Classification of Hypoglycemia (ACH) [17].”
Influential
Metadata
- Authors
- International Hypoglycaemia Study Group
- Corresponding author
- International Hypoglycaemia Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-10
- Volume
- 40
- Issue
- 1
- Pages
- 155-157
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4247704066
- Cited by
- 608
- References
- 24
- Citations by year
- 2026: 34 · 2025: 37 · 2024: 50 · 2023: 61 · 2022: 76 · 2021: 60 · 2020: 93 · 2019: 86 · 2018: 73 · 2017: 36 · 2016: 2
- FWCI
- 55.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0515-10079)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia, glucose concentration, hypoglycemic events, clinical trial reporting, hypoglycemia definition, European Association for the Study of Diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.